Who is sponsoring NCT03980496?

NCT03980496 is sponsored by Medical University of Bialystok.

What drugs are being tested in NCT03980496?

Interventions in NCT03980496: Omeprazole.

What condition does NCT03980496 study?

NCT03980496 studies Non-variceal Upper Gastrointestinal Bleeding.

Is NCT03980496 still recruiting?

NCT03980496 is currently completed. Last updated 10 June 2019.

Last reviewed 2019-06-10 · How we verify

NCT03980496

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding

Completed Phase 4 Last updated 10 June 2019

What this trial tests

Phase 4 trial testing Omeprazole in Non-variceal Upper Gastrointestinal Bleeding in 50 participants. Completed in 8 June 2013.

Timeline

9 September 2010

Primary endpoint
8 June 2013

8 June 2013

Quick facts

Lead sponsor	Medical University of Bialystok
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	9 September 2010
Primary completion	8 June 2013
Estimated completion	8 June 2013
Sites	1 location across Poland

Drugs / interventions tested

Omeprazole (omeprazole) — full drug profile →

Conditions studied

Non-variceal Upper Gastrointestinal Bleeding — all drugs for Non-variceal Upper Gastrointestinal Bleeding →

Sponsor

Medical University of Bialystok

Who can join

Adults 18 to 90, any sex, with Non-variceal Upper Gastrointestinal Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to identify the best method of omeprazole (OME) application with respect to intragastric pH, cytochrome P450 2C19 (CYP2C19) genotype and phenotype.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Omeprazole

Trials testing the same drug.

NCT07214662 — A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Gire · Phase 1 · recruiting
NCT07223671 — Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy · Phase 1 · completed
NCT07235748 — Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvas · Phase 1 · completed
NCT07149415 — A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's S · Phase 1 · completed
NCT06948006 — A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omepr · Phase 1 · completed

Other recruiting trials for Non-variceal Upper Gastrointestinal Bleeding

Currently open trials in the same condition.

NCT07261228 — The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper · recruiting

Other Medical University of Bialystok trials

Trials by the same sponsor.

NCT07496957 — Preserflo MicroShunt Versus Trabeculectomy · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07325552 — iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment · NA · recruiting
NCT07529145 — Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment · recruiting
NCT06855979 — The Impact of Dietary Intervention on Oxidative/antioxidant Markers and Gut Microbiota in Athletes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03980496 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Bialystok
Last refreshed: 10 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03980496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing